J Subst Abuse Treat. 2005 Apr;28(3):273-80.

Adoption of naltrexone to treat alcohol dependence.

Fuller BE, Rieckmann T, McCarty D, Smith KW, Levine H.

Source

Department of Public Health and Preventive Medicine, Oregon Health and Science University, Portland, OR 97239, USA. fullerb@ohsu.edu

Abstract

Three surveys (1997, 1999, and 2001) of outpatient substance abuse treatment centers in Connecticut, Massachusetts, Rhode Island, Maine, Vermont, and New Hampshire examined organizational characteristics that influenced the adoption of naltrexone. Structural equation modeling with manifest variables assessed predictors related to the use of naltrexone. Use of naltrexone increased over time from 14% in 1997 to 25% in 2001. In 1997, programs funded by managed care were more likely, and clinics that provided only substance abuse services were less likely to use psychiatric medication and naltrexone. In subsequent years, counselor education level and organization size also influenced use of naltrexone.

PMID:: 15857728; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

R01-AA11363/AA/NIAAA NIH HHS/United States

LinkOut - more resources

Full Text Sources

Other Literature Sources

Molecular Biology Databases

NALTREXONE - HSDB

Supplemental Content

Save items

Related citations in PubMed

Adoption and implementation of new technologies in substance abuse treatment. [J Subst Abuse Treat. 2002]
Adoption and implementation of new technologies in substance abuse treatment.
Roman PM, Johnson JA. J Subst Abuse Treat. 2002 Jun; 22(4):211-8.
Organizational-level predictors of adoption across time: naltrexone in private substance-use disorders treatment centers. [J Stud Alcohol Drugs. 2007]
Organizational-level predictors of adoption across time: naltrexone in private substance-use disorders treatment centers.
Oser CB, Roman PM. J Stud Alcohol Drugs. 2007 Nov; 68(6):852-61.
Characteristics of U.S. substance abuse treatment facilities adopting buprenorphine in its initial stage of availability. [Drug Alcohol Depend. 2006]
Characteristics of U.S. substance abuse treatment facilities adopting buprenorphine in its initial stage of availability.
Koch AL, Arfken CL, Schuster CR. Drug Alcohol Depend. 2006 Jul 27; 83(3):274-8. Epub 2006 Jan 18.
Review Alcohol abuse and alcoholism: an overview. [J Clin Psychiatry. 2001]
Review Alcohol abuse and alcoholism: an overview.
Volpicelli JR. J Clin Psychiatry. 2001; 62 Suppl 20:4-10.
Review Trends in the adoption of medications for alcohol dependence. [J Clin Psychopharmacol. 2006]
Review Trends in the adoption of medications for alcohol dependence.
Ducharme LJ, Knudsen HK, Roman PM. J Clin Psychopharmacol. 2006 Dec; 26 Suppl 1:S13-9.

See reviews... See all...

Cited by 17 PubMed Central articles

Adoption and implementation of medications in addiction treatment programs. [J Addict Med. 2011]
Adoption and implementation of medications in addiction treatment programs.
Knudsen HK, Abraham AJ, Roman PM. J Addict Med. 2011 Mar; 5(1):21-7.
Advancing performance measures for use of medications in substance abuse treatment. [J Subst Abuse Treat. 2011]
Advancing performance measures for use of medications in substance abuse treatment.
Thomas CP, Garnick DW, Horgan CM, McCorry F, Gmyrek A, Chalk M, Gastfriend DR, Rinaldo SG, Albright J, Capoccia VA, et al. J Subst Abuse Treat. 2011 Jan; 40(1):35-43. Epub 2010 Oct 8.
Organizational factors associated with the use of contingency management in publicly funded substance abuse treatment centers. [J Subst Abuse Treat. 2011]
Organizational factors associated with the use of contingency management in publicly funded substance abuse treatment centers.
Bride BE, Abraham AJ, Roman PM. J Subst Abuse Treat. 2011 Jan; 40(1):87-94. Epub 2010 Sep 17.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Adoption of naltrexone to treat alcohol dependence.
Adoption of naltrexone to treat alcohol dependence.
J Subst Abuse Treat. 2005 Apr ;28(3):273-80.

PubMed
Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat bra...
Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain.
Brain Res Mol Brain Res. 2005 Apr 27 ;135(1-2):162-8. Epub 2005 Jan 22 .

PubMed
Physicians' ability to diagnose sepsis in newborns and critically ill children.
Physicians' ability to diagnose sepsis in newborns and critically ill children.
Pediatr Crit Care Med. 2005 May ;6(3 Suppl):S120-5.

PubMed
Phototherapy of atopic dermatitis with ultraviolet radiation.
Phototherapy of atopic dermatitis with ultraviolet radiation.
Acta Derm Venereol Suppl (Stockh). 1992 ;171:1-37.

PubMed
Histologic chorioamnionitis and severity of illness in very low birth weight new...
Histologic chorioamnionitis and severity of illness in very low birth weight newborns.
Pediatr Crit Care Med. 2005 May ;6(3):298-302.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: